Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,045 | 55,006 | 98,159 | 108,098 | 189,205 |
| Marketable Securities | 283,112 | 331,240 | 485,005 | 526,886 | 553,997 |
| Receivables | 20,595 | 11,891 | 7,324 | 13,200 | 20,265 |
| Other current assets | 0 | 0 | 0 | 0 | 5,989 |
| TOTAL | $385,055 | $400,638 | $593,806 | $656,572 | $776,092 |
| Non-Current Assets | |||||
| PPE Net | 54,533 | 64,225 | 80,083 | 95,991 | 80,377 |
| Investments And Advances | 65,216 | 24,937 | 18,863 | 26,433 | 26,433 |
| Other Non-Current Assets | 44,194 | 55,653 | 31,659 | 36,724 | 42,229 |
| TOTAL | $163,943 | $144,815 | $130,605 | $159,148 | $149,039 |
| Total Assets | $548,998 | $545,453 | $724,411 | $815,720 | $925,131 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 14,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,210 | 6,660 | 12,306 | 16,745 | 11,628 |
| Accrued Expenses | 59,596 | 94,656 | 100,355 | 33,769 | 35,848 |
| Other current liabilities | 2,988 | 4,688 | 4,660 | 230 | N/A |
| TOTAL | $100,243 | $153,745 | $139,067 | $64,597 | $91,553 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,997 | 19,997 | 18,460 | 5,000 | N/A |
| Deferred Revenues | 31,449 | 47,741 | 7,746 | 11,888 | 39,498 |
| Other Non-Current Liabilities | 188,731 | 317,925 | 322,268 | 320,845 | 315,000 |
| TOTAL | $209,579 | $356,267 | $392,499 | $372,542 | $358,227 |
| Total Liabilities | $309,822 | $510,012 | $531,566 | $437,139 | $449,780 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 109,735 | 81,207 | 78,184 | 76,502 | 75,335 |
| Common Shares | 1,081 | 807 | 780 | 764 | 751 |
| Retained earnings | -989,584 | -786,167 | -619,920 | -423,153 | -314,532 |
| Other shareholders' equity | -16,281 | -13,031 | 1,578 | 6,764 | 11,114 |
| TOTAL | $239,176 | $35,441 | $192,845 | $378,581 | $475,351 |
| Total Liabilities And Equity | $548,998 | $545,453 | $724,411 | $815,720 | $925,131 |